Boehringer Ingelheim has a second positive trial under its belt for nerandomilast in pulmonary fibrosis, setting up regulatory filings. The new data from the 1,178-patient FIBRONEER-ILD study ...

Teamwork: A Multidisciplinary Approach to Early Lung Cancer: Personalized Care A nurse practitioner with NYU's pulmonary intervention team chronicles the NSCLC patient experience from diagnosis to ...

A jet-setting Labor MP flew abroad on five occasions in just seven months on trips that cost the taxpayer thousands of dollars - but curiously posted photos on social media taken in his constituen ...

Treatment can help symptoms and slow disease progression. Chronic obstructive pulmonary disease, commonly referred to as COPD, is a group of progressive lung diseases. An estimated 32 million ...

Apr. 22, 2025 — Researchers have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly and currently incurable lung disease that affects more than 3 million people ...

The Johns Hopkins T-cell Lymphoma Program provides expertise in all forms of systemic peripheral T-cell lymphomas, including mycosis fungoides and others. Each week our team of oncologists and ...

Atezolizumab Plus Bevacizumab-induced Recalcitrant Pyoderma Gangrenosum Treated with Baricitinib: A Case Report.

Pakistan has levelled another bizarre and baseless allegation against India, claiming the terrorists who were gunned down by its security forces while trying to infiltrate through the ...